Prevalence of vitamin D deficiency and consequences for PTH reference values

Clinica Chimica Acta

Volumn 426, Issue , 2013, Pages 41-45

  Deckers, M M L ^a   de Jongh, R T ^b   Lips, P T A M ^b   Penninx, B W J H ^b   Milaneschi, Y ^b   Smit, J H ^b   van Schoor, N M ^b   Blankenstein, M A ^b   Heijboer, A C ^b  

^a ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

BMI; PTH; Reference value; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; EDETIC ACID; PARATHYROID HORMONE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE CLEARANCE; FEMALE; GENDER; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN EXPERIMENT; KIDNEY FUNCTION; LIMIT OF QUANTITATION; LONGITUDINAL STUDY; MALE; NORMAL HUMAN; PARATHYROID HORMONE BLOOD LEVEL; PREVALENCE; PRIORITY JOURNAL; REFERENCE VALUE; TANDEM MASS SPECTROMETRY; VITAMIN D DEFICIENCY;

25-HYDROXYVITAMIN D; 25OHD; BMI; BODY MASS INDEX; CHRONIC KIDNEY DISEASE; CHRONIC KIDNEY DISEASE MINERAL AND BONE DISORDER; CKD; CKD-MBD; GFR; GLOMERULAR FILTRATION RATE; KDIGO; KDOQI; KIDNEY DISEASE: IMPROVING GLOBAL OUTCOMES; LASA; LONGITUDINAL AGING STUDY AMSTERDAM; NATIONAL KIDNEY FOUNDATION-KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE; NESDA; NETHERLANDS STUDY OF DEPRESSION AND ANXIETY; PARATHYROID HORMONE; PTH; REFERENCE VALUE; VITAMIN D;

ADOLESCENT; ADULT; AGED; FEMALE; HUMANS; MALE; MIDDLE AGED; PARATHYROID HORMONE; PREVALENCE; REFERENCE VALUES; VITAMIN D DEFICIENCY; YOUNG ADULT;

EID: 84884389637     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.08.024     Document Type: Article

References (34)

1. Cantor T., Yang Z., Caraiani N., Ilamathi E. Lack of comparability of intact parathyroid hormone measurements among commercial assays for end-stage renal disease patients: implication for treatment decisions. Clin Chem 2006, 52:1771-1776.
2. Moe S.M., Drueke T.B., Block G.A., et al. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention and treatment of chronic kidney disease mineral and bone disorder (CKD-MBD). Kidney Int Suppl 2009, 113:S1-S130.
3. Souberbielle J.C., Boutten A., Carlier M.C., et al. Inter-method variability in PTH measurement: implication for the care of CKD patients. Kidney Int 2006, 70:345-350.
4. Almond A., Ellis A.R., Walker S.W. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease. Ann Clin Biochem 2012, 49:63-67.
5. Torres A., Lorenzo V., Hernandez D., et al. Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 1995, 47:1434-1442.
6. Lehmann G., Stein G., Huller M., Schemer R., Ramakrishnan K., Goodman W.G. Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry. Kidney Int 2005, 68:1206-1214.
7. Wesseling K., Bakkaloglu S., Salusky I. Chronic kidney disease mineral and bone disorder in children. Pediatr Nephrol 2008, 23:195-207.
8. Sturgeon C.M., Sprague S.M., Metcalfe W. Variation in parathyroid hormone immunoassay results-a critical governance issue in the management of chronic kidney disease. Nephrol Dial Transplant 2011, 26:3440-3445.
9. Cavalier E., Delanaye P., Vranken L., et al. Interpretation of serum PTH concentrations with different kits in dialysis patients according to the KDIGO guidelines: importance of the reference (normal) values. Nephrol Dial Transplant 2012, 27:1950-1956.
10. Eastell R., Arnold A., Brandi M.L., et al. Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab 2009, 94:340-350.
11. Aloia J.F., Feuerman M., Yeh J.K. Reference range for serum parathyroid hormone. Endocr Pract 2006, 12:137-144.
12. Rejnmark L., Vestergaard P., Heickendorff L., Mosekilde L. Determinants of plasma PTH and their implication for defining a reference interval. Clin Endocrinol (Oxf) 2011, 74:37-43.
13. Souberbielle J.C., Cormier C., Kindermans C., et al. Vitamin D status and redefining serum parathyroid hormone reference range in the elderly. J Clin Endocrinol Metab 2001, 86:3086-3090.
14. Huisman M., Poppelaars J., van der H.M., et al. Cohort profile: the longitudinal aging study Amsterdam. Int J Epidemiol 2011, 40:868-876.
15. Sohl E., van Schoor N.M., de Jongh R.T., de Vries O.J., Lips P. The impact of medication on vitamin D status in older individuals. Eur J Endocrinol 2012, 166:477-485.
16. Penninx B.W., Beekman A.T., Smit J.H., et al. The Netherlands Study of Depression and Anxiety (NESDA): rationale, objectives and methods. Int J Methods Psychiatr Res 2008, 17:121-140.
17. Heijboer A.C., Blankenstein M.A., Kema I.P., Buijs M.M. Accuracy of 6 routine 25-hydroxyvitamin D assays: influence of vitamin D binding protein concentration. Clin Chem 2012, 58:543-548.
18. Milaneschi Y., Hoogendijk W.J., Lips P., et al. The association between low vitamin D and depressive disorders. Mol Psychiatry 2013, 1-8.
19. Gault M.H., Longerich L.L., Harnett J.D., Wesolowski C. Predicting glomerular function from adjusted serum creatinine. Nephron 1992, 62:249-256.
20. Levey A.S., Coresh J., Greene T., et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007, 53:766-772.
21. Sohl E., Jongh R.T., Heijboer A.C., et al. Vitamin D status is associated with physical performance: the results of three independent cohorts. Osteoporos Int 2013, 24:187-196.
22. Ross A.C., Taylor C.L., Yaktine A.L., Del Valle H.B. Dietary Reference Intakes for Calcium and Vitamin D 2011.
23. Twomey P.J., Whitlock T., Pledger D.R. Differences between serum and plasma for intact parathyroid hormone measurement in patients with chronic renal failure in routine clinical practice. J Clin Pathol 2005, 58:1000-1001.
24. Joly D., Drueke T.B., Alberti C., et al. Variation in serum and plasma PTH levels in second-generation assays in hemodialysis patients: a cross-sectional study. Am J Kidney Dis 2008, 51:987-995.
25. Cavalier E., Delanaye P., Hubert P., Krzesinski J.M., Chapelle J.P., Rozet E. Estimation of the stability of parathyroid hormone when stored at -80 degrees C for a long period. Clin J Am Soc Nephrol 2009, 4:1988-1992.
26. Brinc D., Chan M.K., Venner A.A., et al. Long-term stability of biochemical markers in pediatric serum specimens stored at -80 degrees C: a CALIPER Substudy. Clin Biochem 2012, 45:816-826.
27. van der Meer I., Boeke A.J., Lips P., et al. Fatty fish and supplements are the greatest modifiable contributors to the serum 25-hydroxyvitamin D concentration in a multiethnic population. Clin Endocrinol (Oxf) 2008, 68:466-472.
28. Kamycheva E., Sundsfjord J., Jorde R. Serum parathyroid hormone level is associated with body mass index. The 5th Tromsø study. Eur J Endocrinol 2004, 151:167-172.
29. Harvey A., Hu M., Gupta M., et al. A new, vitamin D-based, multidimensional nomogram for the diagnosis of primary hyperparathyroidism. Endocr Pract 2012, 18:124-131.
30. Shapses S.A., Lee E.J., Sukumar D., Durazo-Arvizu R., Schneider S.H. The effect of obesity on the relationship between serum parathyroid hormone and 25-hydroxyvitamin D in women. J Clin Endocrinol Metab 2013, 98:E886-E890.
31. Richert L., Trombetti A., Herrmann F.R., et al. Age and gender distribution of primary hyperparathyroidism and incidence of surgical treatment in a European country with a particularly high life expectancy. Swiss Med Wkly 2009, 139:400-404.
32. Lundgren E., Rastad J., Thrufjell E., Akerstrom G., Ljunghall S. Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women. Surgery 1997, 121:287-294.
33. Jorde R., Bonaa K.H., Sundsfjord J. Primary hyperparathyroidism detected in a health screening. The Tromso study. J Clin Epidemiol 2000, 53:1164-1169.
34. Rejnmark L., Avenell A., Masud T., et al. Vitamin D with calcium reduces mortality: patient level pooled analysis of 70,528 patients from eight major vitamin D trials. J Clin Endocrinol Metab 2012, 97:2670-2681.